General information about company | |
| Name of The Company | Valiant Communications Limited |
| BSE Scrip Code | 526775 |
| NSE Symbol | |
| MSE Symbol | |
| Date of Start of Financial Year | 01-04-2021 |
| Date of End of Financial Year | 31-03-2022 |
| Reporting Period | First half yearly |
| Date of Start of Reporting Period | 01-04-2021 |
| Date of End of Reporting Period | 30-09-2021 |
| Level of rounding used in financial results | Lakhs |
| Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | Yes |
Related party transactions | |||||||||||
A. Details of related party | Sr | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||
| Name of the related party | Mr. Inder Mohan Sood | Mr. Davinder Mohan Sood | Mr. Gaurav Mohan Sood | Mr. Manish Kumar | Mr. Gaurav Kaura | Mr. Avinash Verma | Mr. Sumit Mehta | Ms. Neepa Chatterjee | |||
| Categories of related parties | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | |||
| description of relationship | Chairman and Managing Director | Executive Director -Finance | Wholetime Director | Company Secretary | Independent Director | Independent Director | Independent Director | Independent Director | |||
| PAN of related party | AAWPS7834G | AAWPS7833B | BPXPS3509H | AMEPK5951G | ASBPK4256B | AADPV5183G | AMVPM3910G | AAAPC2951L | |||
| CIN of related party | |||||||||||
B. Details of related party transactions | Purchase of goods and services | ||||||||||
| Sale of goods and services | |||||||||||
| Purchase of fixed assets | |||||||||||
| Sale of fixed assets | |||||||||||
| Rendering of services | |||||||||||
| Receiving of services | |||||||||||
| Leases | |||||||||||
| Loans and advances given | |||||||||||
| Loans and advances taken | |||||||||||
| Loans and advances given that are repaid | |||||||||||
| Loans and advances taken that are repaid | |||||||||||
| Deposits placed | |||||||||||
| Deposits taken | |||||||||||
| Transfer of research & development | |||||||||||
| Transfers under lease agreement | |||||||||||
| Equity investment | |||||||||||
| Impairment in equity investment | |||||||||||
| Expense for bad or doubtful debts | |||||||||||
| Guarantees or collateral given | |||||||||||
| Guarantees or collateral taken | |||||||||||
| Interest income | |||||||||||
| Interest paid | |||||||||||
| Dividend income | |||||||||||
| Dividend paid | |||||||||||
| Management contracts including for deputation of employees | |||||||||||
| Settlement of liabilities by entity on behalf of related party | |||||||||||
Remuneration | Short term employee benefits | 18.3 | 16.68 | 8.7 | 11.172 | ||||||
| Post employment benefits | |||||||||||
| Other long-term benefits | |||||||||||
| Termination benefits | |||||||||||
| Share based payments | |||||||||||
| Others | 0.2 | 0.2 | 0.2 | 0.2 | |||||||
C. Outstanding balances | Receivables | Secured | |||||||||
| Un Secured | |||||||||||
Payables | Secured | ||||||||||
| Un Secured | 2.252 | 2.082 | 1.15 | 1.424 | |||||||
Loans and advances given | Secured | ||||||||||
| Un Secured | |||||||||||
Loans and advances taken | Secured | ||||||||||
| Un Secured | |||||||||||
Deposits placed | Secured | ||||||||||
| Un Secured | |||||||||||
Deposits taken | Secured | ||||||||||
| Un Secured | |||||||||||
Guarantees or collateral given | Secured | ||||||||||
| Un Secured | |||||||||||
Guarantees or collateral taken | Secured | ||||||||||
| Un Secured | |||||||||||
Investment in equity | Secured | ||||||||||
| Un Secured | |||||||||||
Provision for doubtful debt | Secured | ||||||||||
| Un Secured | |||||||||||
Note | The remuneration of directors and key executives is determined by the remuneration committee having regard to the performance of individuals and market trends. It is exclusive of compensated expenses, gratuity and premium paid for group health insurance, as separate actuarial valuation / premium paid are not available. | The remuneration of directors and key executives is determined by the remuneration committee having regard to the performance of individuals and market trends. It is exclusive of compensated expenses, gratuity and premium paid for group health insurance, as separate actuarial valuation / premium paid are not available. | The remuneration of directors and key executives is determined by the remuneration committee having regard to the performance of individuals and market trends. It is exclusive of compensated expenses, gratuity and premium paid for group health insurance, as separate actuarial valuation / premium paid are not available. | The remuneration of directors and key executives is determined by the remuneration committee having regard to the performance of individuals and market trends. It is exclusive of compensated expenses, gratuity and premium paid for group health insurance, as separate actuarial valuation / premium paid are not available. | Sitting fee only | Sitting fee only | Sitting fee only | Sitting fee only | |||